The technology behind the weekly pill is as much mechanical as it is pharmaceutical. Encased in a standard-size capsule is a ...

In a Phase III clinical trial conducted by MIT spinout Lyndra Therapeutics, the researchers used the once-a-week pill to deliver a widely used medication for managing the symptoms of schizophrenia ...

Medically reviewed by Michael MacIntyre, MDSchizophrenia medication falls under two main categories: older, first-generation, ...

Researchers say people with schizophrenia are facing an "epidemic" of obesity-related diseases, with weight gain a common side effect of antipsychotic drugs.

A Phase 3 clinical trial of a new once-weekly risperidone pill for schizophrenia shows it delivers comparable therapeutic effects to daily treatment, offering improved convenience and potential ...

MIT researchers developed a pill that can be taken once a week instead of daily, gradually releasing medication from within the stomach. In a phase 3 clinical trial, the treatment maintained ...

A pill taken just once a week, gradually releasing medicine from within the stomach, can greatly simplify the drug schedule ...

DelveInsight’s, “Schizophrenia Pipeline Insight” report provides comprehensive insights about 55+ companies and 60+ pipeline ...

For around 70 years, the treatment of schizophrenia has relied almost entirely on drugs that block dopamine receptors, so Cobenfy's action on cholinergic receptors offers a brand new way to treat ...

In a review study, researchers reported that omega-3 supplements may lessen the severity of schizophrenia symptoms in teens and young adults, especially those with low levels of omega-3s.

After decades of antipsychotic drugs, a new FDA-approved treatment for schizophrenia targets a different brain system—with ...